Patents Assigned to FUGENBIOPHARMA CO., LTD.
  • Blood pressure lowering composition containing as active ingredient exopolysaccharide produced by means of
    Patent number: 10702564
    Abstract: The present invention relates to a blood pressure lowering composition which contains as an active ingredient exopolysaccharide produced by means of Ceriporia lacerata, a Ceriporia lacerata mycelium culture medium comprising same, or dry powder or an extract of same. The composition can be used as an antihypertensive for preventing or treating hypertension or cerebral apoplexy or as a functional health food having antihypertensive effect.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: July 7, 2020
    Assignee: FUGENBIOPHARMA CO., LTD.
    Inventor: Yoon Soo Kim
  • BLOOD PRESSURE LOWERING COMPOSITION CONTAINING AS ACTIVE INGREDIENT EXOPOLYSACCHARIDE PRODUCED BY MEANS OF CERIPORIA LACERATA
    Publication number: 20170360860
    Abstract: The present invention relates to a blood pressure lowering composition which contains as an active ingredient exopolysaccharide produced by means of Ceriporia lacerata, a Ceriporia lacerata mycelium culture medium comprising same, or dry powder or an extract of same. The composition can be used as an antihypertensive for preventing or treating hypertension or cerebral apoplexy or as a functional health food having antihypertensive effect.
    Type: Application
    Filed: November 3, 2015
    Publication date: December 21, 2017
    Applicant: FUGENBIOPHARMA CO., LTD.
    Inventor: Yoon Soo KIM
  • Method for protecting kidney function
    Patent number: 9717769
    Abstract: The present invention relates to a method for protecting a kidney, which comprises administering an extracellular polysaccharide produced by Ceriporia lacerata; a mycelial culture medium of Ceriporia lacerata containing the extracellular polysaccharide; dried powders of the mycelial culture medium; or an extract of the mycelial culture medium, in an effective amount, to a subject in need of protecting a kidney. The method is effective in protecting a kidney from renal toxicity caused by an anti-cancer agent.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: August 1, 2017
    Assignee: FUGENBIOPHARMA CO., LTD.
    Inventors: Yoon Soo Kim, Hye Dong Yoo, Eun Ji Shin